TrueNorth Launches Sensibiotics in India

TrueNorth launches Sensibiotics targeting $4.91 billion gut health market in India

Overview

TrueNorth has launched innovative probiotic solutions ‘Sensibiotics’ for sensitive gut and feminine health, targeting India's growing gut health market projected at $4.91 billion and feminine health market projected at $0.9 billion in revenues. 

Other Products

• TrueNorth has also launched two new products ‘Sensibiotics’ for sensitive gut and feminine health, tailored to the needs of today’s professionals. 
• These probiotic supplements address common health concerns like travellers' diarrhoea and urinary tract infections (UTIs), providing targeted, preventive care.

Projected Market Size

With this launch, TrueNorth aims to secure a significant position in India's projected market size of gut health and feminine health of $4.91 billion and $0.9 billion respectively in revenues in 2024. 

Sensibiotics

• Sensibiotics for sensitive gut (SG) combines lactobacillus rhamnosus GG (ATCC 53103), the most researched probiotic strain globally, with Saccharomyces Boulardii, encapsulated in Smart Release Technology (SRT) capsules for enhanced delivery. 
• This formulation offers a preventive approach to common gastrointestinal issues, making it a distinct solution for maintaining gut health.
• For feminine wellness, Sensibiotics for Feminine Health features a potent mix of probiotic strains, including Lactobacillus Crispatus, Lactobacillus Gasseri, Lactobacillus Johnsonii, and Lactobacillus Rhamnosus GG (ATCC 53103), also utilizing SRT capsule technology. 
• This product stands out as a preventive solution, aiming to maintain feminine health proactively, in contrast to the reactive, curative solutions commonly available. 

Words from TrueNorth

"In today's world, where stress and urban lifestyle pressures are at an all-time high, TrueNorth is dedicated to providing health-conscious individuals with innovative solutions tailored to their needs. Our Sensibiotics range is designed to proactively manage health challenges associated with frequent travel and daily hustle, ensuring wellness remains a priority. As we continue to lead in the health and wellness supplement market, our focus on specific health concerns through advanced formulations and technology signifies our commitment to enhancing individual well-being and redefining global health supplement standards." says co-founders Sahil Samra and Twinkle Samra. 

Recent Studies on Lactobacillus Rhamnosus

• Recent research by AIIMS, published in Clinical Immunology, shows that Lactobacillus Rhamnosus (LR) can help manage a serious lung condition called ARDS, which is important for combating diseases like Covid-19. 
• TrueNorth's Sensitive Gut and Feminine Health products contain Lactobacillus Rhamnosus GG, a type of LR, which could enable them to do more than just improve gut and urinary health and may play a key role in protecting against lung problems. 

Product’s Availability

• Consumers can avail of both products through TrueNorth's website and on leading health apps like Apollo and TATA 1mg. 
• The brand plans to significantly broaden its impact on health and wellness through its expansive range of supplements. 
• Their future lineup, encompassing probiotics, enzymes, vitamins, and a host of other innovative offerings in the nutraceutical category reflects the brand’s commitment to meeting the evolving health needs of a global community. 
• By integrating these diverse supplements into its product portfolio, TrueNorth aims to offer comprehensive solutions that support the well-being of individuals navigating the complexities of modern, high-stress lifestyles. 

About TrueNorth

• TrueNorth is at the forefront of the health and wellness supplement industry and is dedicated to delivering targeted, scientifically backed probiotic solutions. 
• With a commitment to addressing specific health issues through advanced formulations and cutting-edge technology, TrueNorth is devoted to improving the health and well-being of individuals worldwide.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!